Start Date
May 31, 2024
Primary Completion Date
January 1, 2026
Study Completion Date
January 1, 2028
Electrocardiogram
ECG to monitor electrical activities of the heart on each visit
Echocardiogram
Echocardiogram at baseline and 6 months
Cardiac magnetic resonance imaging
Cardiac MRI at baseline and 6 months
Mobile cardiac telemetry
Mobile cardiac telemetry at baseline and 6 months
Blood pressure monitoring
Home blood pressure monitoring three times per week
Blood draw
Blood draw at baseline, 3 and 6 months
Collaborators (1)
AstraZeneca
INDUSTRY
Dana-Farber Cancer Institute
OTHER